Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D H Nieman

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Psychological Medicine|May 30, 2017
Cerebral dopamine deficiency, plasma monoamine alterations and neurocognitive deficits in adults with phenylketonuriaE Boot, C E M Hollak, S C J Huijbregts, et al.
NPJ Schizophrenia|June 27, 2018
NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders-medium-term follow-up and clinical courseB Nelson, G P Amminger, H P Yuen, et al.
Schizophrenia Research|December 24, 2019
Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomesS Youn, L J Phillips, G P Amminger, et al.
Schizophrenia Research|December 13, 2018
Dynamic prediction of transition to psychosis using joint modellingH P Yuen, A Mackinnon, J Hartmann, et al.
Schizophrenia Research|April 20, 2020
Do schizotypal or borderline personality disorders predict onset of psychotic disorder or persistent attenuated psychotic symptoms in patients at high clinical risk?H Hadar, H Zhang, L J Phillips, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Psychological Medicine|May 30, 2017
Cerebral dopamine deficiency, plasma monoamine alterations and neurocognitive deficits in adults with phenylketonuriaE Boot, C E M Hollak, S C J Huijbregts, et al.
NPJ Schizophrenia|June 27, 2018
NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders-medium-term follow-up and clinical courseB Nelson, G P Amminger, H P Yuen, et al.
Schizophrenia Research|December 24, 2019
Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomesS Youn, L J Phillips, G P Amminger, et al.
Schizophrenia Research|December 13, 2018
Dynamic prediction of transition to psychosis using joint modellingH P Yuen, A Mackinnon, J Hartmann, et al.
Schizophrenia Research|April 20, 2020
Do schizotypal or borderline personality disorders predict onset of psychotic disorder or persistent attenuated psychotic symptoms in patients at high clinical risk?H Hadar, H Zhang, L J Phillips, et al.
Pageof 3